Read + Share
Miller JS, Davis ZB, Helgeson E, Reilly C, et al. Safety and virologic impact of the IL-15 superagonist N-803 in people living with
HIV: a phase 1 trial. Nat Med 2022 Jan 31. pii: 10.1038/s41591-021-01651.
PMID: 35102335
|
 |
|
Miller JS, Davis ZB, Helgeson E, Reilly C, et al. Safety and virologic impact of the IL-15 superagonist N-803 in people living with
HIV: a phase 1 trial. Nat Med 2022 Jan 31. pii: 10.1038/s41591-021-01651.
PMID: 35102335
|
|
|
|